Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novartis Institutes For Biomedical Research
AddedFeb 13, 2024
UpdatedJun 28, 2026
Novartis Institutes For Biomedical Research

Novartis Institutes For Biomedical Research

Novartis Institutes For Biomedical Research: A noncommercial research organization founded in 2002.

HQ
Cambridge, MA, US
Founded
2002
Overview
Compare
Employees
Website

Founded in 2002, Novartis Institutes for Biomedical Research (NIBR) is a noncommercial research organization within Novartis. Its core mission is to drive drug discovery and early development by uncovering insights into the origins and pathogenesis of diseases. NIBR focuses on delivering transformative medicines to combat disease, restore possibilities, and improve quality of life. The organization operates across various disease areas, leveraging cutting-edge research and development to maintain an industry-leading pipeline of innovative treatments.

NIBR is affiliated with notable researchers and scientists who contribute to its pioneering work in biomedical research. It has achieved significant milestones in drug discovery and development, contributing to the broader impact of Novartis in the pharmaceutical industry. Through its relentless focus on innovation and scientific excellence, NIBR has made substantial contributions to advancing medical science and improving patient outcomes worldwide.

Quick Facts

When was Novartis Institutes For Biomedical Research founded?

Novartis Institutes For Biomedical Research was founded in 2002.

Where is Novartis Institutes For Biomedical Research's headquarters located?

Novartis Institutes For Biomedical Research's headquarters is located in Cambridge, MA, US.

How many employees does Novartis Institutes For Biomedical Research have?

Novartis Institutes For Biomedical Research has 10,000 employees as of Feb 5, 2024.

Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Healthtech
NAICS
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 611000Educational Services
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8200Educational Services
Show 1 more industry code
SIC
  • 8290Schools And Educational Services, Not Elsewhere Classified